Cyclobenzaprine pills come in a wide range of colors, shapes, and sizes depending on the dose, the manufacturer, and whether the formulation is immediate-release or extended-release. The original brand-name version, Flexeril, is no longer on the market, so virtually every cyclobenzaprine pill dispensed today is a generic. That means two people taking the same dose from different pharmacies can end up holding pills that look nothing alike. Understanding what to expect, and how to confirm you have the right medication, is more practical than it sounds.
Immediate-Release Tablets and Their Common Appearances
Cyclobenzaprine immediate-release tablets are approved in 5 mg, 7.5 mg, and 10 mg strengths. The 5 mg tablets are the most commonly prescribed starting dose for short-term muscle spasm relief, and they tend to be small, round, and film-coated. Depending on the manufacturer, you might see a 5 mg pill that is yellow, orange, peach, or even white. The 10 mg tablets follow a similar pattern: round and film-coated, often yellow or butterscotch-colored, though some generics are white or light orange. The 7.5 mg strength, introduced later as a lower-dose option, is typically round and orange, but again, the exact shade varies by maker.
The original Flexeril 10 mg tablet had a distinctive D-shape (sometimes described as a modified rectangle with rounded edges) in a butterscotch yellow color, with “FLEXERIL” debossed on one side. That specific shape largely disappeared from pharmacies once the brand was discontinued, but you still occasionally see references to it in older drug guides. If someone hands you a D-shaped yellow tablet and calls it cyclobenzaprine, it is almost certainly old stock or a leftover from a long-expired prescription rather than anything currently manufactured.
Extended-Release Capsules
Cyclobenzaprine also comes in an extended-release formulation, originally marketed under the brand name Amrix. These are capsules rather than tablets and look quite different from the immediate-release pills. The 15 mg capsule is typically blue and orange (or blue and white, depending on the generic manufacturer), while the 30 mg capsule is often orange and orange or red-orange. Because they are capsules with beads inside rather than compressed tablets, they are noticeably larger than the small round immediate-release pills. You should not open, crush, or chew an extended-release capsule, since the bead design is what allows the drug to release slowly over time.
Why Generic Versions Look So Different From Each Other
Generic drug manufacturers are required to match the active ingredient, dose, and bioequivalence of the original brand product, but they are free to choose their own inactive ingredients, coatings, dyes, and shapes. That freedom is why one pharmacy’s cyclobenzaprine 10 mg might be a round yellow pill stamped “V 2632” while another’s is a round butterscotch tablet stamped “M 751.” Neither is fake. Both contain 10 mg of cyclobenzaprine hydrochloride. The letters and numbers pressed into the surface (known as imprint codes) are assigned by each manufacturer so that any pill can be traced back to its maker and its contents.
Color differences come down to the dyes used in the film coating. Some manufacturers use FD&C Yellow No. 6 for an orange look, others use iron oxide for a more muted peach, and still others skip coloring agents entirely and produce a plain white tablet. None of these cosmetic differences affect the drug’s activity. If your pharmacy switches suppliers and your refill looks different from your last bottle, that alone is not a reason for concern, though it is always worth double-checking the imprint to confirm the identity and dose.
How to Verify a Cyclobenzaprine Pill
Every prescription tablet and capsule sold in the United States is required by the FDA to carry a unique imprint code. If you are unsure whether a pill is cyclobenzaprine, the most reliable step is to use the imprint code stamped on it. The FDA’s own online pill identifier, as well as tools maintained by major pharmacy databases, let you type in the imprint, select the pill’s color and shape, and get a match. This is far more dependable than trying to identify a pill by color alone, since dozens of unrelated medications share colors like “round, yellow, film-coated.”
A few practical tips for checking:
- Read both sides: Many cyclobenzaprine tablets have a number or letter code on one side and a score line or a second marking on the other. Enter both into the identifier tool.
- Note the shape precisely: “Round” covers most immediate-release versions, but some generics are oval or oblong. Capsules are always listed separately from tablets.
- Check for a score line: Some 10 mg tablets have a line across one face, which might suggest the manufacturer intended the pill to be split. Not all do, and whether it should be split is a separate question.
If the imprint code does not match any known cyclobenzaprine product, do not take the pill. Bring it to your pharmacist for identification.
The Tablet-Splitting Problem
Because cyclobenzaprine is available in both 5 mg and 10 mg immediate-release tablets, some prescribers write for 10 mg tablets with instructions to split them in half for a 5 mg dose. This seems straightforward, especially if the tablet has a score line. In practice, though, it is less reliable than it looks. A study that tested splitting unscored generic cyclobenzaprine 10 mg tablets found that the fragment weights varied considerably, meaning the estimated drug content in each half was unpredictable. The researchers concluded that splitting these tablets to achieve a 5 mg dose could lead to inconsistent dosing and an unreliable therapeutic response.1PubMed. Variability in tablet fragment weights when splitting unscored cyclobenzaprine 10 mg tablets
If your prescription says to take half a tablet, it is worth asking your pharmacist whether the 5 mg tablet is available from their supplier. Taking a whole 5 mg pill removes the guesswork entirely. And if you are splitting a scored tablet, a proper pill splitter gives more even halves than snapping with your fingers, though even scored tablets do not guarantee perfect halves every time.
Newer Formulations Under Development
Researchers have been working on sublingual cyclobenzaprine tablets, designed to dissolve under the tongue rather than be swallowed whole. These formulations look different from standard oral tablets: they are typically smaller, designed to disintegrate rapidly, and engineered to allow the drug to pass through the tissue lining the mouth. One research effort developing a sublingual cyclobenzaprine tablet showed that focused formulation work could substantially improve how much drug permeated through the oral mucosa. However, the study also found that changes in the tablet’s salt form under stress conditions (a process called salt disproportionation) reduced permeation by about a third, highlighting how sensitive these newer dosage forms are to storage and manufacturing conditions.2PubMed Central. Formulation Development of Sublingual Cyclobenzaprine Tablets Empowered by Standardized and Physiologically Relevant Ex Vivo Permeation Studies
If a sublingual version reaches the market in the future, it would likely look like a small, flat disc, possibly with a different texture than a standard swallowed tablet. It would not be interchangeable with regular cyclobenzaprine tablets, since the route of absorption and the dose would differ. For now, the options you will encounter at a pharmacy are standard immediate-release tablets and extended-release capsules.
Why Cyclobenzaprine Can Be Confused With Other Medications
Beyond the visual similarity between generics, cyclobenzaprine has an unusual chemical quirk that makes it look like something else at a molecular level too. Its chemical structure is nearly identical to that of amitriptyline, a tricyclic antidepressant, differing by only one double bond.3PubMed. Cyclobenzaprine hydrochloride This resemblance is close enough that cyclobenzaprine is often flagged as a tricyclic antidepressant on urine toxicology screens. Older laboratory assays have such a hard time telling the two apart that their retention times differ by only seconds, and the color stains they produce are nearly identical.4PubMed. Effect of cyclobenzaprine on tricyclic antidepressant assays
This matters in a couple of real-world scenarios. If you take cyclobenzaprine and then have a drug test, the result may come back positive for tricyclic antidepressants even though you have never taken one. Emergency physicians see this regularly: a patient arrives with symptoms that could be a TCA overdose, the tox screen lights up for tricyclics, and the clinical team has to figure out whether the patient actually took amitriptyline or just has cyclobenzaprine on board. If you are taking cyclobenzaprine and end up in an emergency department for any reason, mention it early so the team does not chase a misleading lab result.
Storing Your Pills and What Degradation Looks Like
Cyclobenzaprine tablets should be stored at room temperature, away from moisture and direct light. Like most film-coated tablets, they are fairly stable under normal household conditions. However, if a tablet has been exposed to heat or humidity for a prolonged period, the film coating may become sticky, discolored, or crumbly. A tablet that has changed color from its original appearance, developed spots, or crumbled at the edges may have undergone chemical degradation and should not be taken.
The sensitivity of cyclobenzaprine formulations to environmental stress is well documented in pharmaceutical research. As noted in the sublingual tablet study described above, even controlled stress conditions altered the salt form of the drug enough to reduce its ability to permeate tissue by roughly a third.2PubMed Central. Formulation Development of Sublingual Cyclobenzaprine Tablets Empowered by Standardized and Physiologically Relevant Ex Vivo Permeation Studies Standard swallowed tablets are more forgiving because they dissolve in the acidic environment of the stomach, but the general principle holds: a pill that looks wrong may not work right. If you find an old bottle and the tablets look noticeably different from when they were dispensed, discard them safely rather than gambling on potency.
Common Misconceptions About Cyclobenzaprine Pill Appearance
One persistent misunderstanding is that a “real” cyclobenzaprine pill should be a specific color, usually yellow. This belief traces back to the original Flexeril branding, which was distinctively yellow. In reality, there is no single correct color for cyclobenzaprine. A white pill, a peach pill, and an orange pill can all be legitimate cyclobenzaprine from different generic manufacturers. Color is cosmetic, not pharmacological.
Another misconception is that the size of a pill reflects how much drug it contains. Cyclobenzaprine tablets are generally small because the active ingredient dose is low (5 to 10 mg), but the total tablet size depends heavily on the amount of filler, binder, and coating the manufacturer uses. A 10 mg tablet from one company might be noticeably larger than a 10 mg tablet from another, yet both deliver the same dose. Extended-release capsules are larger still, not because they contain more drug per dose but because the bead-based delivery system takes up physical space inside the capsule shell.
A third area of confusion involves pills purchased online or obtained outside the usual pharmacy chain. Counterfeit medications are a real problem globally, and muscle relaxants like cyclobenzaprine are sometimes counterfeited because of their demand. Researchers have been developing electroanalytical methods to identify pharmaceutical tablets, including cyclobenzaprine, by their chemical fingerprint rather than by visual inspection alone.5Chinese Journal of Analytical Chemistry. Drug identification by electroanalysis with multiple classification approaches These forensic tools are not something a consumer has at home, which is exactly why buying medications from verified, licensed pharmacies matters. A pill that looks right is not necessarily right. The imprint code, the dispensing pharmacy’s records, and the manufacturer’s lot number on the bottle label are your best defenses against counterfeits.
When Your Refill Looks Different
Pharmacy suppliers change frequently. Your pharmacy might stock cyclobenzaprine from one generic company this month and a different one next month, purely based on pricing contracts and availability. When this happens, you open your new bottle and find pills that are a completely different color or shape from what you took before. This switch is legal, normal, and usually harmless. The pharmacist is required to dispense a product that is bioequivalent to what was prescribed, regardless of who made it.
That said, some people do notice differences in how they feel after a supplier switch. While the active drug is the same, the inactive ingredients (fillers, coatings, dyes) can differ, and in rare cases a person may have a sensitivity or mild allergy to a particular inactive ingredient. If you notice an unusual reaction after a generic switch, it is worth reporting to your pharmacist. They can often order from a specific manufacturer on request, or your prescriber can write “do not substitute” for a particular generic if needed. The drug itself has not changed. But the vehicle carrying it into your body is slightly different, and for a small number of people, that distinction is felt.